HDAC9 and cancer: This contrasts with the results reported by Kim et al., who demonstrated that HDACi-mediated promotion of cisplatin cytotoxicity was produced only when the cancer cells were pre-treated with the HDAC inhibitors before the cells were exposed to anticancer drugs like cisplatin [14].